Monday, January 19, 2009

FDA Regulations Still a Concern for Digital Communications

Pin It Now!
Even though many pharma companies are catching up with online pharmaceutical marketing, FDA regulations that include rules against promoting a product’s possible off-label uses and requirements for drug companies to clearly disclose potential side effects and risks still stand for web marketing. This article on CQPolitics discusses how many drug companies have been slower than usual in adopting social media practices in their marketing efforts.

Most pharma companies only have experience with online ads and creating static web pages, but that might soon change with the new administration focusing on the development of web portals and communities.
Post a Comment